Canopy Growth (CGC) Net Margin (2019 - 2026)
Canopy Growth (CGC) posted Net Margin of 7.47% for Q3 2025, down 244.38% sequentially from 5.17% in Q3 2024, and down 1264.0% YoY from 0.64% in Q3 2024.
Canopy Growth (CGC) Net Margin (2019 - 2026) Analysis & Trends
Canopy Growth has reported Net Margin for 7 years, with the latest figure at 7.47% in Q3 2025.
- Quarterly Net Margin fell 1264.0% year-over-year to 7.47% in Q3 2025, while the trailing twelve-month figure through Dec 2025 was 1.18% (down 396.0% YoY) and the FY2026 annual result came in at 8.08%, down 12017.0% from the prior year.
- Net Margin declined to 7.47% in Q3 2025 per CGC's latest filing, from 5.17% in the prior quarter.
- Over five years, Net Margin peaked at 286.29% in Q2 2021 and troughed at 1762.71% in Q2 2022.
- A 5-year average of 123.9% and a median of 26.73% in 2021 frame the typical range for Net Margin.
- The sharpest annual moves came in 2021 and 2022: Net Margin soared 469707 bps in 2021, then plunged 204900 bps in 2022.
- Over 5 years, Net Margin stood at 74.5% in 2021, then soared by 41 bps to 44.23% in 2022, then surged by 139 bps to 17.17% in 2023, then plunged by 70 bps to 5.17% in 2024, then plunged by 244 bps to 7.47% in 2025.
- According to Business Quant data, Net Margin over the past three periods registered 7.47%, 5.17%, and 3.1% for Q3 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - | - |
| 10 | Canopy Growth | 451.82 Mn | 204.81 Mn | 16.08 Mn | -14.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.53% |
| Sep 30, 2025 | -7.47% |
| Sep 30, 2024 | 5.17% |
| Jun 30, 2024 | 3.10% |
| Mar 31, 2024 | 3.21% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | -253.81% |
| Jun 30, 2023 | -41.03% |
| Mar 31, 2023 | -51.30% |
| Dec 31, 2022 | -44.23% |
| Sep 30, 2022 | -124.34% |
| Jun 30, 2022 | -1,762.71% |
| Mar 31, 2022 | 149.15% |
| Dec 31, 2021 | -74.50% |
| Sep 30, 2021 | -12.43% |
| Jun 30, 2021 | 286.29% |
| Mar 31, 2021 | -74.67% |
| Dec 31, 2020 | -4,771.57% |
| Sep 30, 2020 | -71.38% |
| Jun 30, 2020 | -107.75% |